Walgreens Recognizes Pharmacist’s Curiosity With Highest Honor
NORTHAMPTON, MA / ACCESSWIRE / March 7, 2024 / Walgreens Boots Alliance:
A pursuit of innovation and improvement earns pharmacist Ahlam Antar Walgreens' top award appreciating team members for their talent and engagement.
Originally published by Walgreens Boots Alliance
By Mike Huffman
Meet Ahlam Antar, pharmacist and registered group supervisor at our Mansfield, Massachusetts, microfulfillment center that fills thousands of prescriptions for Walgreens patients across New England. Her constant curiosity, one of WBA's values, led her leaders and teammates to recognize her as a Champion of Champions in Walgreens' companywide awards program and she was chosen as the Pinnacle Winner, the highest honor in the program.
"I just tend to ask a lot of questions. I want to know why we do things a specific way and then always see if I can improve them, make it faster, quicker, easier," she says, crediting her experience as an immigrant for her inquisitive nature.
Watch the video above to learn how Antar has made an impact for patients and why her teammates think she thrives in her role. Congratulations, Ahlam!
View additional multimedia and more ESG storytelling from Walgreens Boots Alliance on 3blmedia.com.
Contact Info:
Spokesperson: Walgreens Boots Alliance
Website: https://www.3blmedia.com/profiles/walgreens-boots-alliance
Email: info@3blmedia.com
SOURCE: Walgreens Boots Alliance
View the original press release on accesswire.com
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand